Contribute Try STAT+ Today

When He Jiankui unveiled data last week on the two baby girls born from embryos whose genes he had edited with CRISPR-Cas9 — the world’s first “CRISPR babies” — his 59 slides flew by in a 20-minute blur, leaving scientists in the audience of the International Summit on Human Genome Editing desperately taking iPhone pictures for later scrutiny.

Now many of them, as well as researchers who watched the webcast of the Hong Kong summit, have had time to analyze the data. The verdict: What He did is way worse than initially realized.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.